Results posted for dexmedetomidine study in dementia agitation
Results for this study were first posted on ClinicalTrials.gov on October 1, 2026. The study, a Phase 3, randomized, double-blind, placebo-controlled trial, enrolled 13 participants and was terminated.
Primary source
ClinicalTrials.gov results record, October 1, 2026
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
Read the source: Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation